Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response

No abstract is available for this paper.

• Publication year

  2023

• Venue

  British Journal of Cancer

• Publication date

  2023-06-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41416-023-02327-6PMID 37355722PMCID PMC10421921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Roles of CD4+ T cells as mediators of antitumor immunity

  2022cited by this paper
• Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses

  2022cited by this paper
• Multipurposing CARs: Same engine, different vehicles

  2022cited by this paper
• Immunogenic cell stress and death

  2022influential reference
• An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives

  2022cited by this paper
• The A to I editing landscape in melanoma and its relation to clinical outcome

  2022cited by this paper
• Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

  2022cited by this paper
• Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.

  2022cited by this paper
• Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity

  2022cited by this paper
• Regression of Breast Cancer Metastases Following Treatment with Irradiated SV-BR-1-GM, a GM-CSF Overexpressing Breast Cancer Cell Line: Intellectual Property and Immune Markers of Response

  2022cited by this paper
• Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.

  2022cited by this paper
• Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

  2022cited by this paper
• Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy

  2022cited by this paper
• Human dendritic cells in cancer

  2022cited by this paper
• Cancer vaccines: the next immunotherapy frontier

  2022cited by this paper
• An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases

  2022cited by this paper
• Cancer vaccines as promising immuno-therapeutics: platforms and current progress

  2022cited by this paper
• Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

  2022cited by this paper
• Epigenetic modulation of antitumor immunity for improved cancer immunotherapy

  2021cited by this paper
• Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6

  2021cited by this paper
• The future of tumor vaccines in the post‐COVID‐19 era—Current challenges

  2021cited by this paper
• Graphene-Induced Hyperthermia (GIHT) Combined With Radiotherapy Fosters Immunogenic Cell Death

  2021cited by this paper
• Cancer Vaccines: Promising Therapeutics or an Unattainable Dream

  2021cited by this paper
• Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.

  2021cited by this paper
• Therapeutic cancer vaccines

  2021cited by this paper
• C‐type lectin receptors MR and DC‐SIGN are involved in recognition of hemocyanins, shaping their immunostimulatory effects on human dendritic cells

  2021cited by this paper
• Emerging concepts in the science of vaccine adjuvants

  2021influential reference
• Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future

  2021cited by this paper
• Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death

  2021cited by this paper
• Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma

  2021influential reference
• Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

  2021cited by this paper
• Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors.

  2020cited by this paper
• Enhancing anti-tumour efficacy with immunotherapy combinations.

  2020cited by this paper
• Unexplored horizons of cDC1 in immunity and tolerance.

  2020cited by this paper
• Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity

  2020cited by this paper
• Dendritic cells in the tumor microenvironment: prognostic and theranostic impact.

  2020cited by this paper
• Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy

  2020influential reference
• PD-L1-Mediated Gasdermin C Expression Switches Apoptosis to Pyroptosis in Cancer Cells and Facilitates Tumor Necrosis

  2020cited by this paper
• Emerging connectivity of programmed cell death pathways and its physiological implications

  2020cited by this paper
• Antigen-loaded monocyte administration induces potent therapeutic anti-tumor T cell responses.

  2020cited by this paper
• Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update

  2020cited by this paper
• Cellular cytotoxicity is a form of immunogenic cell death

  2020cited by this paper
• Cell death induced by cytotoxic CD8+ T cells is immunogenic and primes caspase-3–dependent spread immunity against endogenous tumor antigens

  2020cited by this paper
• Role of RNA modifications in cancer

  2020cited by this paper
• Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells

  2020cited by this paper
• The Role of Antigen Spreading in the Efficacy of Immunotherapies

  2020cited by this paper
• Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy.

  2020cited by this paper
• Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial

  2020cited by this paper
• A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth

  2020influential reference
• A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer

  2020cited by this paper
• Metabolic support of tumor-infiltrating regulatory T cells by lactic acid

  2020cited by this paper
• Ferroptosis becomes immunogenic: implications for anticancer treatments

  2020cited by this paper
• Necroptosis in Immuno-Oncology and Cancer Immunotherapy

  2020cited by this paper
• Antitumour dendritic cell vaccination in a priming and boosting approach

  2020cited by this paper
• BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers

  2020cited by this paper
• Turning the corner on therapeutic cancer vaccines

  2019cited by this paper
• Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity.

  2019cited by this paper
• Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen

  2019cited by this paper
• The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

  2019cited by this paper
• CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy

  2019cited by this paper
• Talimogene laherparepvec: review of its mechanism of action and clinical efficacy and safety.

  2019cited by this paper
• Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity

  2019cited by this paper
• Dendritic cells in cancer immunology and immunotherapy

  2019cited by this paper
• Dendritic Cells Loaded with Heat Shock-Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell-Dependent Antitumor Immune Responses In Vitro

  2019cited by this paper
• Bacillus Calmette–Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections

  2019cited by this paper
• Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy.

  2019cited by this paper
• Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells

  2019cited by this paper
• Cold Tumors: A Therapeutic Challenge for Immunotherapy

  2019cited by this paper
• Peptides as cancer vaccines.

  2019cited by this paper
• Cancer immunotherapy using checkpoint blockade

  2018cited by this paper
• Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

  2018cited by this paper
• Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer

  2018cited by this paper
• In vivo cancer vaccination: Which dendritic cells to target and how?

  2018cited by this paper
• Biomanufacturing for clinically advanced cell therapies

  2018cited by this paper
• The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity

  2018cited by this paper
• Cytokines in clinical cancer immunotherapy

  2018cited by this paper
• Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report

  2018cited by this paper
• Successful Anti‐PD‐1 Cancer Immunotherapy Requires T Cell‐Dendritic Cell Crosstalk Involving the Cytokines IFN‐&ggr; and IL‐12

  2018cited by this paper
• From Ocean to Bedside: the Therapeutic Potential of Molluscan Hemocyanins.

  2018cited by this paper
• Shared cancer neoantigens: Making private matters public

  2018cited by this paper
• Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks

  2018cited by this paper
• Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

  2017cited by this paper
• Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment

  2017cited by this paper
• Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

  2017cited by this paper
• PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.

  2017influential reference
• Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.

  2017cited by this paper
• Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells

  2017cited by this paper
• Elements of cancer immunity and the cancer–immune set point

  2017cited by this paper
• Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin

  2017cited by this paper
• Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

  2017cited by this paper
• Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions

  2017cited by this paper
• An immunogenic personal neoantigen vaccine for patients with melanoma

  2017cited by this paper
• Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells

  2017cited by this paper
• Toll‐like receptor 3 stimulation triggers metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF

  2017cited by this paper
• Immunotherapy of Uveal Melanoma: Vaccination Against Cancer.

  2017cited by this paper
• T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.

  2016cited by this paper
• Global burden of cancers attributable to infections in 2012: a synthetic analysis.

  2016cited by this paper
• Vaccines for established cancer: overcoming the challenges posed by immune evasion

  2016cited by this paper
• TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles)

  2016cited by this paper
• Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines

  2016cited by this paper

• pH‐Responsive Biomineralized Probiotic for Self‐Amplifying Mucosal Vaccination: Gut‐Engineered Antigen Factories Drive Targeted Cervical Tumor Regression

  2026cites this paper
• Overcoming functional and translational challenges of cellular immunotherapies for solid tumors.

  2026cites this paper
• Probiotic-Driven Therapeutic Vaccine for in Vivo Reprogramming of Tumor Cells To Elicit Postoperative Antitumor Immunity.

  2026cites this paper
• Synergistic whole-cell Cancer vaccine combining immunogenic cell death and TLR9 agonist elicits potent prophylactic and therapeutic antitumor immunity.

  2026cites this paper
• Fgl2-knockout tumor cells serve as a vaccine inducing long-duration brain-resident memory T cells that reject subsequent intracranial tumor cell challenges.

  2025cites this paper
• Immunotherapy in Breast Cancer: Beyond Immune Checkpoint Inhibitors

  2025cites this paper
• Recent advances in therapeutic cancer vaccines

  2025cites this paper
• Multimodal Regulation of Dendritic Cells via Mineralized Vaccines for Postsurgical Tumor Relapse Prevention.

  2025cites this paper
• Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapy

  2025cites this paper
• Cancer Vaccines: A Promising Therapeutic Strategy in Advanced Solid Tumors

  2025cites this paper
• Establishment of whole tumor cell antigen-induced cellular immunotherapy for lung adenocarcinoma

  2025cites this paper
• Ex vivo engineering of phagocytic signals in breast cancer cells for a whole tumor cell-based vaccine

  2025cites this paper
• Construction strategies of whole tumor cell vaccines.

  2025cites this paper
• Prospects and Challenges of Lung Cancer Vaccines

  2025cites this paper
• Overcoming cancer immunotherapy barriers via nanomaterial-mediated pyroptosis.

  2025cites this paper
• Calreticulin Enhances Therapeutic Immune Responses of Dry Thermostat-Stressed Hepatocellular Carcinoma Cell Vaccine.

  2025cites this paper
• Therapeutic cancer vaccines in pancreatic cancer

  2025cites this paper
• Therapeutic Vaccination in Lung Cancer: Past Attempts, Current Approaches and Future Promises

  2025cites this paper
• Combined Tumor Cell and Lysate-Based Vaccines for Immunotherapy of Primary and Recurrent Glioblastoma (GBM)

  2025cites this paper
• Conformational stability of hemocyanins regulates their lysosomal and proteasomal degradation, influencing their pro-inflammatory effects on mammalian antigen-presenting cells

  2025cites this paper
• Gastrointestinal cancer: molecular pathogenesis and targeted therapy

  2025cites this paper
• PLGA Nanoencapsulation Enhances Immunogenicity of Heat-Shocked Melanoma Tumor Cell Lysates

  2025cites this paper
• Turning the tide: harnessing vaccines and viruses to fight cancer

  2025cites this paper
• The anti-tumor effect of the IFNγ/Fas chimera expressed on CT26 tumor cells

  2025cites this paper
• VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens

  2025cites this paper
• Potential and development of cellular vesicle vaccines in cancer immunotherapy

  2025cites this paper
• Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers

  2025cites this paper
• Whole-Component Antigen Nanovaccines Combined With aTIGIT for Enhanced Innate and Adaptive Anti-tumor Immunity.

  2025cites this paper
• Reconfiguring the immune system to target cancer: Therapies based on T cells, cytokines, and vaccines.

  2025cites this paper
• The Role of Therapeutic Vaccines in Cancer Immunotherapy

  2025cites this paper
• A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma Multiforme

  2025cites this paper
• Translational Advances in Oncogene and Tumor-Suppressor Gene Research

  2025cites this paper
• Enhanced Whole Tumor Cell-Based Vaccines by a RAFT and Protein Fusion Strategy for Tumor Immunotherapy.

  2025cites this paper
• Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges

  2025cites this paper
• Engineering bioactive mineralized tumor cells for tumor immunotherapy

  2025cites this paper
• Emerging Targets and Therapeutics in Immuno-Oncology: Insights from Landscape Analysis

  2024cites this paper
• Hydrogel activation of Mincle receptors for tumor cell processing: A novel approach in cancer immunotherapy.

  2024cites this paper
• Boron Neutron Capture Therapy‐Derived Extracellular Vesicles via DNA Accumulation Boost Antitumor Dendritic Cell Vaccine Efficacy

  2024cites this paper
• Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations

  2024cites this paper
• Vaccine-based therapeutic interventions in lung cancer management: A recent perspective

  2024cites this paper
• Recent progress in cancer vaccines and nanovaccines.

  2024cites this paper
• Mechanotransduction-Piloted Whole-Cell Vaccines for Spatiotemporal Modulation of Postoperative Antitumor Immunity.

  2024cites this paper
• Endoplasmic Reticulum Stress Nano‐Orchestrators for Precisely Regulated Immunogenic Cell Death as Potent Cancer Vaccines

  2024cites this paper
• Emerging strategies to overcome ovarian cancer: advances in immunotherapy

  2024cites this paper
• Cancer vaccines: Target antigens, vaccine platforms and preclinical models.

  2024cites this paper
• Vaccine Therapies for Prostate Cancer: Current Status and Future Outlook

  2024cites this paper
• The Landmark Series: Cancer Vaccines for Solid Tumors

  2024cites this paper
• NIR-II-activated whole-cell vaccine with ultra-efficient semiconducting diradical oligomers for breast carcinoma growth and metastasis inhibition

  2024cites this paper
• rWTC‐MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells

  2024cites this paper
• Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy

  2024cites this paper
• Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy

  2024cites this paper
• Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies.

  2024cites this paper
• The quest for nanoparticle-powered vaccines in cancer immunotherapy

  2024cites this paper